Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Leprosy Research Initiative (LRI) is a leading international research funder dedicated to the elimination of leprosy and its associated complications. Established in 2013, it functions as a collaborative venture between several major anti-leprosy organizations, including NLR, American Leprosy Missions, and The Leprosy Mission International. LRI provides a centralized, competitive portal for funding high-quality scientific research that addresses the most urgent needs in the field. The organization focuses on five strategic priority areas: interrupting transmission, preventing disability, promoting social inclusion, developing improved diagnostics, and optimizing treatment regimens. By pooling resources and expertise, LRI aims to bridge the gap between scientific discovery and field implementation to achieve a world free of leprosy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leprosy Research Initiative.